AIM2 and head and neck squamous cell carcinoma: Kaplan–Meier analyses using a maximal risk condition demonstrated that AIM2 upregulation significantly (p = 0.019) was associated with a poorer overall survival in GSE42743 OSCC, but not TCGA HNSCC, patients who received radiotherapy (Fig. 1E).